Caligan Partners’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.3M | Sell |
2,017,352
-132,315
| -6% | -$1.79M | 5.25% | 7 |
|
|
2025
Q1 | $34.1M | Buy |
2,149,667
+1,138,512
| +113% | +$18.1M | 7.12% | 4 |
|
|
2024
Q4 | $12.4M | Buy |
1,011,155
+30,000
| +3% | +$369K | 3.15% | 10 |
|
|
2024
Q3 | $11.9M | Buy |
981,155
+235,397
| +32% | +$2.85M | 3.77% | 9 |
|
|
2024
Q2 | $8.73M | Buy |
+745,758
| New | +$8.73M | 2.04% | 10 |
|